Meanwhile Russo et al., (2016) demonstrated distinct SOX2 expression in the basal cell layer of normal prostate glands and its absence in most of the neoplastic epithelia, with the exception of a few foci of low-grade and high-grade prostate cancer, which agrees with the notion that prostates lose basal cells during cancer progression. This evidence concerns the gene SOX2 and prostate carcinoma.